Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.2325 | 69 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.39608 | 70 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.21638 | 69 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.35794 | 69 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.87908 | 74 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.11934 | 67 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.37807 | 70 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.30986 | 70 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.23392 | 69 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.32019 | 69 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.99084 | 75 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.81696 | 74 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.3801 | 70 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.57298 | 72 |